Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yusuke Matsuzaka, Manabu Noguchi, Shigeki Kanamura, Kengo Maeda, Takahiro Hisano, Daizo Tanaka, Yukihiro Ando, Tomokazu Yamamoto, Yoshiro Morimoto, Hiroki Ozawa & Toshihiro Otsuka. (2022) Combination therapy of modified electroconvulsive therapy and long-acting injectable aripiprazole for dopamine supersensitivity psychosis: a case report. Neurocase 28:3, pages 310-313.
Read now
Read now
Pierre Chue & James Chue. (2016) A review of aripiprazole long-acting injection. Current Medical Research and Opinion 32:3, pages 441-452.
Read now
Read now
Articles from other publishers (4)
Sarah Levaj, Sara Medved, Jasmina Grubišin, Lea Tomašić, Kristina Brozić, Laura Shields-Zeeman, Felix Bolinski & Martina Rojnic Kuzman. (2022) The impact of the COVID-19 pandemic and earthquake on mental health of persons with severe mental illness: A survey study among people receiving community mental health care versus treatment as usual in Croatia. International Journal of Social Psychiatry 69:3, pages 653-663.
Crossref
Crossref
Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar & Prakash S. Masand. (2021) Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?. Clinical Psychopharmacology and Neuroscience 19:3, pages 434-448.
Crossref
Crossref
Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar & Prakash S. Masand. (2021) Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. Clinical Psychopharmacology and Neuroscience 19:2, pages 233-242.
Crossref
Crossref
Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar & Prakash S. Masand. (2020) Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. Clinical Psychopharmacology and Neuroscience 18:1, pages 153-158.
Crossref
Crossref